What is CBC?
First discovered in 1966, CBC is structurally similar to many other cannabinoids like THC and CBD. However, unlike those more notable chemicals, precious little research has been undertaken around the compound.
What is known is that its effect comes via its interactions with endocannabinoid receptors (the complex network of natural cannabinoid receptors within the human body). These receptors, such as CB1 and CB2, are found throughout the body and brain.
The compound is also known to interact with other receptors that activate pain and inflammation transmission signals, such as TRPA1 and TRPV1 receptors. It is these sensors which first alert the brain to pain or swelling.
And it's this ability to interact with different receptor channels which may be the key to CBC’s future in research; while peer-reviewed research into CBC is scarce, the work that has been undertaken has shown some promising results.
In one 2013 study, researchers demonstrated that CBC could be used to encourage new cell growth in mice. In another experiment, scientists from the University of Mississippi found that rat subjects treated with CBC performed better on stress-related tests, indicating that CBC may have a role in reducing anxiety.
In 2010, one group of researchers demonstrated that CBC’s anti-inflammatory properties could be boosted when used in conjunction with THC and CBD. They found that the combination of all three compounds was more effective than the combination of THC and CBD only.
CBC’s oldest known properties are actually anti-bacterial. Studies in the 1980s indicated that CBC might be directly act against deadly bacterial killers like E. coli.
No comments:
Post a Comment